Bethesda, Maryland April 17, 2007 - A forthcoming article entitled: .Dialysis Facility Ownership and Epoetin Dosing in Patients Receiving Hemodialysis. is to be published in the April 18th issue of Journal of the American Medical Association (Thamer et al. Dialysis... JAMA, 2007 Apr 18;297(15):1667-74). Investigators examined epoetin dosing patterns among 159,522 hemodialysis patients and found that dialysis facility epoetin practice patterns are associated with organizational status (independent vs. chain affiliation and for-profit vs. not-for-profit). Specifically, the largest for-profit chains used the highest doses of epoetin regardless of anemia status (i.e. hematocrit level), larger dose adjustments, and target higher hematocrit levels.
Research was supported in part by NIH grant R01-DK066011-01A2
On April 18th, this article can be obtained by linking on: JAMA For more information on our other EPO-related research activities, visit MTPPI or contact:
Dennis J. Cotter
President
Medical Technology and Practice Patterns Institute, Inc.
4733 Bethesda Ave., Suite 510
Bethesda, MD 20814
(301) 652-4005
fax: (301) 652-8335
dcott@mtppi.org